R&D Partner Content 7th TPD & Induced Proximity Summit Fast-Track Discovery, Development & Approval of Selective, Safe & Clinically Relevant TACs & Glues for Degradation, Stabilization, & Phosphorylation to Successfully Address
R&D Partner Content 5th Gene Therapy Immunogenicity Summit Optimise Safety & De-Risk Efficacy of Viral Vector Based Gene Therapies
R&D Partner Content 2nd CRISPR-Based Therapy Analytical Development Summit Fostering Analytical Gold Standards for Genome Editing Therapies
R&D Partner Content 3rd Lipid Nanoparticles Development Summit Europe Unlock LNP potential with enhanced clinical translatability at the 3rd Lipid Nanoparticles Development Summit Europe (24-26 September, Berlin, Germany), the leading dedicated LNP f
R&D Partner Content ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summi... Collaborate, license, and partner to reduce risks, validate technologies, and acquire clinically ready assets
R&D Partner Content 6th Gene Therapy Analytical Development & CMC Summit Execute Robust Analytical & Process Development Strategies for Complex Gene Therapies
News UK says it has hit target on commercial trial set-up times The UK has made progress in its efforts to slash set-up times for clinical trials, one of the factors blamed for a decline in industry-backed studies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.